The U.S. Food and Drug Administration on Tuesday approved the first generic Symbicort drug used to treat asthma and chronic obstructive pulmonary disease (COPD), which are two common pulmonary health ...

Harvard Pilgrim Health Care has entered into its third outcomes-based pharmaceutical contract tying what it pays for drugs to how well the patient does on the medicine. In its most recent agreement, ...

The FDA on March 15 approved the first generic version of Symbicort inhalation aerosol to treat asthma and chronic obstructive pulmonary disease. The generic drug-device combination product is a ...

(Reuters) -AstraZeneca breached the UK pharmaceutical industry's code of practice after a website claim incorrectly stated that all newly diagnosed asthma patients aged 12 and above should receive its ...

LONDON (Reuters) - Novartis is working with British inhaled drug specialist Vectura Group on generic versions of today's blockbuster asthma drugs, the head of the Swiss company's generics business has ...